- Home
- CRNX vs TBBK Comparison
CRNX vs TBBK Comparison
Compare CRNX & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | TBBK |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.6B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CRNX | TBBK |
|---|---|---|
| Price | $47.18 | $66.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $71.00 | $68.00 |
| AVG Volume (30 Days) | ★ 1.4M | 467.1K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.10 |
| EPS | N/A | ★ 4.78 |
| Revenue | $1,535,000.00 | ★ $523,163,000.00 |
| Revenue This Year | $425.31 | N/A |
| Revenue Next Year | $943.50 | $32.53 |
| P/E Ratio | ★ N/A | $13.80 |
| Revenue Growth | ★ 47.74 | 10.84 |
| 52 Week Low | $24.10 | $40.51 |
| 52 Week High | $60.34 | $81.65 |
Technical Indicators
Market Signals| Indicator | CRNX | TBBK |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 52.39 |
| Support Level | $44.52 | $63.00 |
| Resistance Level | $48.62 | $67.43 |
| Average True Range (ATR) | 2.00 | 1.92 |
| MACD | 0.29 | 0.95 |
| Stochastic Oscillator | 72.38 | 86.48 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.